Enliven Therapeutics, Inc. (ELVN): 4 filed Mar 22, 2024

Form type

4

Filing date

Mar 22, 2024

Accession number

0001415889-24-009019

Filer

Enliven Therapeutics, Inc. (CIK 1672619)